Podcasts about barnes jewish hospital

In the third edition of a special podcast series, CancerNetwork® spoke with Daniel Morgensztern, MD; Mary Ellen Flanagan, NP; and Janelle Mann, PharmD, BCOP, about optimal strategies for incorporating different therapeutic agents into lung cancer care. As part of the latest discussion, the group highlighted the relevant efficacy data, administration protocols, and toxicity management considerations associated with TROP2-directed antibody-drug conjugates (ADCs) in patients with non–small cell lung cancer (NSCLC). Morgensztern is a professor of Medicine and the clinical director of Thoracic Oncology in the Division of Oncology at Washington University School of Medicine in St. Louis. Flanagan is a nurse practitioner in the Division of Thoracic Oncology at Washington University. Mann is a clinical oncology pharmacist at Siteman Cancer Center of Washington University School of Medicine and manager of Clinical Pharmacy Services at Barnes-Jewish Hospital. Morgensztern opened the discussion by highlighting the characteristics of prominent TROP2-targeting ADCs in NSCLC management, which included sacituzumab govitecan-hziy (Trodelvy), datopotamab deruxtecan-dlnk (Datroway), and sacituzumab tirumotecan (sac-TMT). Additionally, he reviewed data from clinical trials assessing these ADCs across different NSCLC populations, including the phase 3 EVOKE-01 trial (NCT05089734) showing a numerical overall survival (OS) improvement with sacituzumab govitecan vs docetaxel. Regarding the safety profiles of these ADCs, Flanagan described the unique toxicities associated with the agents' payloads as well as potential off-target effects. On top of myelosuppression, fatigue, and diarrhea, she stated that these therapies may cause more visceral organ toxicities like keratitis of the eye and interstitial lung disease. According to Flanagan, some prophylactic measures in the event of certain toxicities include frequent salt and baking soda mouth rinses as well as oral dexamethasone.  Mann then outlined the dosing variability considerations and supportive care measures surrounding the use of agents like sacituzumab govitecan. She emphasized continuously re-educating patients about expected toxicities and supportive care strategies as they undergo these infusion-based therapies to help avoid surprise instances of ocular toxicity, diarrhea, and other adverse effects. Reference Paz-Ares LG, Juan-Vidal O, Mountzios GS, et al. Sacituzumab govitecan versus docetaxel for previously treated advanced or metastatic non-small cell lung cancer: the randomized, open-label phase III EVOKE-01 study. J Clin Oncol. 2024;42(24):2860-2872. doi:10.1200/JCO.24.00733

Morgan had not turned 45 yet, so she hadn't received a screening colonoscopy for colorectal cancer. But when she noticed blood in her stool at age 41, she did exactly what she should have and sought medical evaluation. After months of missteps became years of dismissive care, she realized it was time for a second opinion at Siteman Cancer Center. With the help of WashU Medicine radiation oncologist Hyun Kim, MD, co-director of the Young-Onset Colorectal Cancer Program, Morgan was given a treatment plan that provided the care she needed. In this episode, we discuss her persistence and dedication to getting herself the best care for her young-onset colorectal cancer diagnosis.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/colorectal/young-onset-colorectal-cancer-program/ https://siteman.wustl.edu/treatment/cancer-types/colorectal/prevention-and-screening/  https://siteman.wustl.edu/doctor/kim-hyun/ https://getscreenednow.com/colon-cancer/ https://getscreenednow.com/insurance/  

In the second edition of a special podcast series, CancerNetwork® spoke with Daniel Morgensztern, MD; Mary Ellen Flanagan, NP; and Janelle Mann, PharmD, BCOP, about the best practices for incorporating recently approved bispecific antibodies into cancer care. This discussion focused on clinical trial results, administration protocols, and adverse effect (AE) management strategies related to the use of tarlatamab-dlle (Imdelltra) for patients with small cell lung cancer (SCLC). Morgensztern is a professor of Medicine and the clinical director of Thoracic Oncology in the Division of Oncology at Washington University School of Medicine in St. Louis. Flanagan is a nurse practitioner in the Division of Thoracic Oncology at Washington University. Mann is a clinical oncology pharmacist at Siteman Cancer Center of Washington University School of Medicine and manager of Clinical Pharmacy Services at Barnes-Jewish Hospital. The conversation opened with Morgensztern highlighting tarlatamab's mechanism of action as an agent that targets DLL3. He then reviewed prior efficacy data that the therapy demonstrated in the phase 1 DeLLphi-300 trial (NCT03319940) and the phase 2 DeLLphi-301 trial (NCT05060016). Of note, the FDA approved tarlatamab as the first available T-cell engager immunotherapy for patients with extensive-stage SCLC who have progressed on prior platinum-containing chemotherapy in May 2024 based on data from the DeLLphi-301 trial. Additionally, Flanagan detailed strategies for monitoring and mitigating the most common AEs associated with tarlatamab in this patient population, which include cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome. Mann then outlined considerations for properly dosing and administering the agent, highlighting factors that clinicians should keep in mind when continuing treatment in an inpatient or outpatient setting. The group also spoke about clinical decision-making related to patients who have brain metastases, which included processes for adjusting the dose of tarlatamab and sequencing the bispecific agent with radiotherapy. Reference FDA grants accelerated approval to tarlatamab-dlle for extensive stage small cell lung cancer. News release. FDA. May 16, 2024. Accessed March 14, 2025. https://tinyurl.com/48k34rw5

In the first edition of a special 3-part podcast series, CancerNetwork® spoke with Daniel Morgensztern, MD; Mary Ellen Flanagan, NP; and Janelle Mann, PharmD, BCOP, about best practices for implementing recently approved bispecific antibodies into cancer care. Their initial discussion focused on the clinical trial results, administration protocols, and toxicity management strategies related to the use of amivantamab-vmjw (Rybrevant) for patients with EGFR-mutated non–small cell lung cancer (NSCLC). Morgensztern is a professor of Medicine and clinical director of Thoracic Oncology in the Division of Oncology at Washington University School of Medicine in St. Louis. Flanagan is a nurse practitioner in the Division of Thoracic Oncology at Washington University in St. Louis. Mann is a clinical oncology pharmacist at Siteman Cancer Center of Washington University School of Medicine in St. Louis and manager of Clinical Pharmacy Services at Barnes-Jewish Hospital. Morgensztern began by giving an overview of amivantamab's mechanism of action and highlighting supporting data for the agent when administered alone or in combination with other agents.  The FDA initially approved amivantamab monotherapy for patients with EGFR exon 20 insertion–mutant NSCLC in May 2021 based on data from the phase 1 CHRYSALIS trial (NCT02609776). Furthermore, the agency approved amivantamab/chemotherapy as frontline treatment for patients with NSCLC harboring EGFR exon 20 insertion mutations in March 2024 based on data from the phase 3 PAPILLON trial (NCT04538664). Findings from the phase 3 MARIPOSA trial (NCT04487080) also supported the FDA approval of amivantamab plus lazertinib (Lazcluze) for those with EGFR-mutant NSCLC in August 2024. Additionally, Mann reviewed key dosing considerations as patients receive amivantamab via intravenous infusion. She detailed the use of premedication such as diphenhydramine (Benadryl) to supplement amivantamab while monitoring for toxicities during the initial infusion period, which may necessitate additional dosing adjustments. Flanagan added to the conversation surrounding infusion-related reactions by describing strategies for mitigating the risk of venous thromboembolism, cutaneous toxicities, and other adverse effects. References 1. RYBREVANTTM (amivantamab-vmjw) receives FDA approval as the first targeted treatment for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. News release. The Janssen Pharmaceutical Companies of Johnson & Johnson. May 21, 2021. Accessed January 29, 2025. https://tinyurl.com/3d8wtu4m 2. FDA approves amivantamab-vmjw for EGFR exon 20 insertion-mutated non-small cell lung cancer indications. News release. FDA. March 1, 2024. Accessed January 29, 2025. https://tinyurl.com/msw4u5yk 3. RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) approved in the U.S. as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer. News release. Johnson & Johnson. August 20, 2024. Accessed January 29, 2025. https://tinyurl.com/yxc8u8t4

To celebrate our 50th episode we are honored to welcome Dr. Robert Bucelli on the show. He is a leading expert in neuromuscular neurology and a dedicated advocate for advancing treatments for neuromuscular disorders.  In this episode, Dr. Bucelli shares his wealth of knowledge on neuromuscular neurology, exploring topics such as: What neuromuscular neurology entails and who is affected. The role of genetics in diagnosing and treating neuromuscular disorders. Common symptoms, risk factors, and diagnostic approaches. How therapies like physical and occupational therapy play a role in management. Lifestyle modifications, including diet and exercise, to minimize risk. The latest advancements in research and treatment, including ASO therapy. Strategies for coping with the challenges of living with neuromuscular conditions. Dr. Bucelli has been a practicing neurologist at the ALS Clinic since 2011. He is an Associate Professor of Neurology at the Washington University School of Medicine in St. Louis where he serves as the Site Principal Investigator on several clinical studies relating to ALS.   After graduating summa cum laude from Canisius College in Buffalo, New York with a degree in biology, Dr. Bucelli went on to receive his medical degree and PhD from the State University of New York at Buffalo as part of the Medical Scientist Training Program. He then completed an internship in internal medicine and postgraduate residency in neurology at Barnes-Jewish Hospital and the Washington University School of Medicine, followed by a postgraduate Clinical Fellowship Training Program in the Department of Neurology's Neuromuscular Section, also at Barnes-Jewish and Washington University. He is also a graduate of the Washington University and Barnes-Jewish Hospital Academic Medical Leadership Program for Physicians and Scientists.   Dr. Bucelli is expert in diagnosing and treating neuromuscular disorders including amyotrophic lateral sclerosis. He also reads and interprets muscle and nerve biopsies to aid in the diagnostic evaluations of patients seen at Washington University and many additional outside institutions. Dr. Bucelli's clinical expertise guides exemplary multidisciplinary ALS care in the neuromuscular clinic. His skill in delivering drugs to the fluid surrounding the spinal cord has enabled Dr. Bucelli's and Washington University's leadership in trials using to turn off the production of harmful genes that cause ALS.   Dr. Bucelli has received numerous awards for excellence in teaching and clinical work at Washington University. He is a five-time recipient of the Eliasson Award for Teaching Excellence and has authored over 40 peer-reviewed manuscripts. He is a frequently invited guest lecturer and presenter at regional and national conferences.   Stay tuned for the next new episode of “It Happened To Me” in the New Year on January 6th, 2025! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    “It Happened To Me” is created and hosted by Cathy Gildenhorn and Beth Glassman. DNA Today's Kira Dineen is our executive producer and marketing lead. Amanda Andreoli is our associate producer. Ashlyn Enokian is our graphic designer.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com.   

It can be scary, difficult and complicated, but it doesn't always have to be. … Lung cancer is the No. 1 cause of cancer deaths — not just because of its aggressive nature, but because it's also frequently diagnosed late. But why? Hear from two survivors about their experiences and the importance of screening, which can catch lung cancer earlier, when it's more treatable.    “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/cancer-types/lung-cancer/ https://siteman.wustl.edu/treatment/cancer-types/lung-cancer/treatments/ https://siteman.wustl.edu/lung-cancer-screening/ https://siteman.wustl.edu/prevention/smoking-cessation-program/ https://siteman.wustl.edu/prevention/ydr/ https://www.smokingpackyears.com/ https://smokefree.gov/ https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/saved-by-the-scan

After minor blurred vision prompted Ellen to get an eye exam, she was surprised to learn she had a mass in the middle of her brain near the nerve connected to her left eye. A referral to Siteman quickly led to the diagnosis of a brain tumor. Fortunately, it was noncancerous and had a surgical solution. Washington University neurosurgeon Albert Kim, MD, PhD, director of The Brain Tumor Center at Siteman, explains minimally invasive surgery techniques and other new treatments that speed recovery for benign tumor patients like Ellen and others facing brain cancer.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/thisiscancer/ https://siteman.wustl.edu/ https://siteman.wustl.edu/neuro-oncology/ https://siteman.wustl.edu/treatment/cancer-types/brain-tumor-center/

When Byron was diagnosed with prostate cancer, he underwent surgery to have it removed. But when doctors noticed his PSA levels were still rising following the procedure, they offered him access to an open clinical trial. Byron shares his experiences from the 6-month trial along with his Washington University radiation oncologist Lannis Hall, MD. From upsides, to side effects, Byron and Dr. Hall use his story to illustrate the benefits of clinical trials, and how each trial's research furthers our understanding and potential cures for cancer.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/research/learn-about-clinical-trials/ https://siteman.wustl.edu/treatment/clinical-trials/ https://siteman.wustl.edu/treatment/clinical-trials/?path=gu-bladder-kidney-prostate-testicular-prostate https://siteman.wustl.edu/treatment/cancer-types/prostate/treatments/radiation-therapy-for-prostate-cancer/ https://siteman.wustl.edu/treatment/cancer-types/prostate/treatments/ https://siteman.wustl.edu/about/dei/

Former NHL player Kelly Chase is known as one of the toughest guys to wear a St. Louis Blues jersey, racking up more than 2,000 penalty minutes in his career. But when his Washington University oncologist Dr. Ramzi Abboud diagnosed him with acute myeloid leukemia in 2023, Chase learned he was facing an opponent different than anything he challenged on the ice – one needing more than brute force.    Listen as Chase and Dr. Abboud share the intense and taxing treatment plan needed to overcome Chase's rare cancer and what Chase learned about himself during his time at Siteman Cancer Center.     “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/thisiscancer/ https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/cancer-types/leukemia/ https://stlbluesalumni.com/Events/Puck-Cancer-Charity-Game  

In January of his senior year, Thomas was stretching and noticed a painless bump on the back of his hamstring. The 3-sport athlete thought nothing of it. But by the spring, the lump had grown to the size of a baseball. Thomas was immediately directed to Siteman kids where Washington University pediatric oncologist, Dr. Amy Armstrong, confirmed the mass was a sarcoma. Listen as Thomas, his mom Amelia, and Dr. Armstrong describe the long, intense treatment plan that delayed his plans for college football, and the mental grit it took to return to the sport he loved. Thomas also shares the advice he has for other young athletes.    After a diagnosis, every Siteman patient and their medical team develops a treatment plan, and every treatment plan becomes as unique as the patient it supports. Chuck learned how to tailor a treatment plan firsthand as he acted as a caregiver to his son, and again when he faced a cancer diagnosis himself. In this episode, Chuck shares his experience alongside Tate Rondot, Siteman's Manager of Support Services. Both are involved in Siteman's Patient and Family Advisory Council (PFAC), a group dedicated to helping every patient create the plan they need during their cancer care. They offer considerations and resources that personalize patients'  treatment from diagnosis to hospice and every stage in between.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/specialized-programs/sarcoma/ https://www.stlouischildrens.org/conditions-treatments/childhood-cancer-survivorship-program https://www.stlouischildrens.org/conditions-treatments/oncology-services/proton-beam-therapy https://siteman.wustl.edu/treatment/cancer-types/childhood-cancers/ https://siteman.wustl.edu/visiting/kids/ https://siteman.wustl.edu/doctor/armstong-amy/ https://siteman.wustl.edu/treatment/cancer-types/sarcoma/

Welcome to Episode 87 of the Sustainable Clinical Medicine Podcast! In today's episode, we are joined by the remarkable Dr. Kemia Sarraf, a physician, internist, and public health professional who has devoted her career to pioneering trauma-informed and trauma-responsive coaching practices. Dr. Sarraf will share her unique insights on recognizing trauma within ourselves to better assist others, grounded in her rich background in internal medicine, public health, and leadership development. We'll delve into the historical context of trauma, how it manifests in healthcare professionals, and practical ways to mitigate it, all while discussing the broader implications for physician burnout and sustainable healthcare environments. Join us as we explore the transformative power of trauma-informed coaching, the critical importance of connection, and strategies for balancing the demands of medical practice with personal well-being. Whether you're a physician, healthcare provider, or simply interested in the dynamics of healthcare, this episode promises to offer valuable perspectives and actionable advice. Stay tuned for an engaging and informative conversation with Dr. Kemia Sarraf. Here are 3 key takeaways from this episode: Understanding Trauma: Trauma is universal and recognizing its manifestations, both overt and subtle, in ourselves is essential to effectively help others. Connection as a Disruptor: Forming meaningful connections and offering clarity in the face of uncertainty can significantly mitigate toxic stress. Rest and Adaptability: Challenging the notion of perfect balance, the focus should shift to planning for the natural ebb and flow of effort and rest, delegating tasks, and sometimes lowering non-critical standards to maintain well-being. Dr. Kemia Sarraf Bio: Dr. Kemia Sarraf (“Dr. K” to friends and clients alike) completed her Medical Degree and Master of Public Health at the University of Utah School of Medicine, and her residency in Internal Medicine at Barnes-Jewish Hospital, Washington University School of Medicine. The arc of her 2+ decade career has included medical practice, public health program development, nonprofit leadership, business ownership, multiple board positions, trauma-mitigation work, and farming. Dr. K founded Lodestar in 2016 specializing in trauma-responsive coaching methods for physician colleagues experiencing high levels of severe burnout, vicarious trauma, and moral injury. Her background in public health and trauma led her to create a unique trauma-responsive coaching paradigm, particularly well-suited for frontline professionals working in environments of chronic toxic stress who directly experience the multivariate ways that vicarious and secondary trauma “shows up” in daily life. Dr. K's program has been applied across multiple industries for both leadership training and in the creation of trauma-responsive cultures for hard-driving, highly skilled professionals in any industry. Dr. K serves as adjunct faculty at Southern Illinois University School of Medicine in the office of Equity, Diversity, and Inclusion, bringing a trauma-informed lens and trauma-mitigation approach to institutional Justice, Equity and Anti-Racism work. She is engaged in multiple leadership initiatives and is co-lead faculty and facilitator in the ACGME Equity Matters program where her unique paradigm focuses on learners at every stage of their medical training and throughout their careers. Kemia is an authentic, compelling storyteller and a powerful keynote speaker. She is the recipient of numerous awards for her leadership and vision and was an AMA Women Physicians Inspiration Award Honoree in 2021. She is renowned for her boundless compassion, wisdom, and humor. Kemia and her physician-husband have been married for twenty years, and the couple live on a small working farm in Central Illinois with their four sons and "too many critters to count." -------------- Would you like to view a transcript of this episode? Click here **** Charting Champions is a premiere, lifetime access Physician only program that is helping Physicians get home with today's work done. All the proven tools, support and community you need to create time for your life outside of medicine. Learn more at https://www.chartingcoach.ca **** Enjoying this podcast? Please share it with someone who would benefit. Also, don't forget to hit “follow” so you get all the new episodes as soon as they are released. **** Come hang out with me on Facebook or Instagram. Follow me @chartingcoach to get more practical tools to help you create sustainable clinical medicine in your life. **** Questions? Comments? Want to share how this podcast has helped you? Shoot me an email at admin@reachcareercoaching.ca. I would love to hear from you.

In this episode, we discuss the challenges of explanting aortic grafts, the diagnosis and management of infected aortic grafts, as well as tips and tricks for once we're in the operating room.   Interviewers/Editors: Mark Basilious, MD Candidate (@markrbasilious) Eva Urrechaga, MD (@urrechisme) Sharif Ellozy, MD (@SharifEllozy)   Guests: Dr. Francis Caputo (@FrankCaputoMD) is an Associate Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, Vascular Surgery Director of the Aorta Center, and Program Director of the Vascular Surgery Training Programs. His clinical interests include complex open and endovascular repair of thoracic, thoracoabdominal, and abdominal aortic aneurysms, management of thoracic dissection, and endovascular and open repair of failed endograft. Dr. Caputo earned his medical degree from the University of Medicine and Dentistry New Jersey, Newark, NJ, where he also served his surgical residency and two years as a National Institutes of Health research fellow. He completed his fellowship in vascular surgery at Barnes-Jewish Hospital of Washington University, St. Louis, MO and joined the Cleveland Clinic medical staff in 2018.    Dr. Peter Rossi (@peterjrossi) is a Professor of Surgery, Radiology, and Orthopedic Surgery, and Chief of the Division of Vascular and Endovascular Surgery at the Medical College of Wisconsin. His primary research and clinical interests are in complex  “re-do” and revision surgery, including for thoracoabdominal and abdominal aortic aneurysms, carotid artery surgery, and renal and mesenteric arterial disease, as well as vascular reconstruction for complicated soft tissue sarcomas. Dr. Rossi completed medical school at the University of Illinois College of Medicine before completing his general surgery training at the University of Chicago and his vascular surgery training at the Medical College of Wisconsin, where he has been a member of the faculty since 2009.  Dr. Xavier Berard (@XavierBerardMD)  is a French vascular surgeon who has been a Consultant in the Department of Vascular Surgery and Professor of Vascular and Endovascular Surgery in Bordeaux University Hospital in Bordeaux, France since 2010 and a full Professor of Vascular Surgery at the University of Bordeaux since 2016. He has also completed a PhD in Vascular Biomaterials and in 2010 worked as a research fellow at Lausanne University Hospital in Switzerland. He has been board certified by the French College of Vascular and Endovascular Surgeons since 2008 and by the European Society for Vascular and Endovascular Surgery since 2010. He has served as an examiner for the FEBVS exam since 2014 and as a reviewer for the European Journal of Vascular and Endovascular Surgery since 2016. Additionally, he is a member of the ESVS guidelines writing group for vascular graft infection and AAA.  His personal surgical interests include open surgery of (thoraco)abdominal aneurysms, redo aortic surgery, infections in vascular surgery, EVAR explantation, and biomaterials. He works closely with Institut Bergonié Bordeaux Cancer Center for sarcomas. You can see educational videos and learn more about Dr. Xavier Berard here. Helpful links and resources: Video of explantation of infected chimney EVAR with duodenal fistula (courtesy of Dr. Berard) Video of reimplanting the IMA after explanting an infected graft Video of explantation of infected graft with suprarenal fixation Videos of using the syringe technique to remove an aortic stent graft here and here (courtesy of Dr. Berard) References Kim YW. Aortic Endograft Infection: Diagnosis and Management. Vasc Specialist Int. 2023 Sep 21;39:26. doi: 10.5758/vsi.230071. PMID: 37732343; PMCID: PMC10512004. Papas TT. Patient Selection Is Essential for Explantation of Infected Abdominal Aortic Endografts. Angiology. 2023 Nov 23:33197231218622. doi: 10.1177/00033197231218622. Epub ahead of print. PMID: 37995099. Anagnostopoulos A, Mayer F, Ledergerber B, Bergadà-Pijuan J, Husmann L, Mestres CA, Rancic Z, Hasse B; VASGRA Cohort Study. Editor's Choice - Validation of the Management of Aortic Graft Infection Collaboration (MAGIC) Criteria for the Diagnosis of Vascular Graft/Endograft Infection: Results from the Prospective Vascular Graft Cohort Study. Eur J Vasc Endovasc Surg. 2021 Aug;62(2):251-257. doi: 10.1016/j.ejvs.2021.05.010. Epub 2021 Jun 14. PMID: 34140225. Lumsden AB. Explant of the Aortic Endograft: Today's Solutions, Tomorrow's Problems. Methodist Debakey Cardiovasc J. 2023 Mar 7;19(2):38-48. doi: 10.14797/mdcvj.1176. PMID: 36936357; PMCID: PMC10022536. Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

The early symptoms were not clear. But after feeling “off” for a few days following a trip abroad, Candice took herself to the ER. Soon after, she was diagnosed with Stage 4 endometrial cancer. She was just 41. With the guidance and expertise of Washington University gynecologic oncologist, Dr. Premal Thaker, Candice welcomes each day, meeting it with unrelenting tenacity and spirit. Dr. Thaker shares about the rise of endometrial cancers in the U.S. (and globally) and discusses the red flag every postmenopausal woman needs to know. Listen to Candice's story and witness the powerful bond between patient and doctor with a common goal: fueling life with hope while facing cancer.    “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.    “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/cancer-types/uterus-endometrial/ https://siteman.wustl.edu/treatment/cancer-types/uterus-endometrial/symptoms-risks-and-diagnosis/ https://siteman.wustl.edu/treatment/cancer-types/uterus-endometrial/genetic-counseling-for-gynecologic-cancers/ https://siteman.wustl.edu/treatment/siteman-psychology-service/ https://getscreenednow.com/ https://siteman.wustl.edu/doctor/premal-thaker-md-ms/ https://siteman.wustl.edu/treatment/specialized-programs/gynecologic-oncology/

After a diagnosis, every Siteman patient and their medical team develops a treatment plan, and every treatment plan becomes as unique as the patient it supports. Chuck learned how to tailor a treatment plan firsthand as he acted as a caregiver to his son, and again when he faced a cancer diagnosis himself. In this episode, Chuck shares his experience alongside Tate Rondot, Siteman's Manager of Support Services. Both are involved in Siteman's Patient and Family Advisory Council (PFAC), a group dedicated to helping every patient create the plan they need during their cancer care. They offer considerations and resources that personalize patients'  treatment from diagnosis to hospice and every stage in between.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/about/committees/patient-and-family-advisory-committee-pfac/ https://siteman.wustl.edu/visiting/patient-and-family-services/ https://siteman.wustl.edu/treatment/cancer-types/brain-tumor-center/ https://siteman.wustl.edu/treatment/cancer-types/prostate/ https://siteman.wustl.edu/treatment/siteman-psychology-service/ https://siteman.wustl.edu/treatment/survivorship/  

Dr. Amjad Musleh, an emergency medicine and intensive care physician at Barnes-Jewish Hospital, volunteered at one of the last functioning hospitals in Gaza last month. He shares why he went to an active war zone to treat Palestinian war victims and how he saw extraordinary examples of human resilience.

Welcome to the Continuous Improvement Podcast with Mark Graban! In this episode, we celebrate Justin Self, Performance Improvement Manager at Barnes Jewish Hospital, and recipient of the prestigious Nexie Award from KaiNexus. Join us as Justin shares his decade-long journey in continuous improvement at BJC Health, highlighting the importance of standardization, grassroots efforts, and leveraging KaiNexus for both top-down and bottom-up improvements.

Caring for a cancer patient can be a daunting undertaking, but also a meaningful act of love. In this episode, Courtney shares her journey as a caregiver for her husband, Charlie. She supported him as he battled a brain tumor for 18 of their 19 years of marriage. Patrick and Laura also share their experiences of caring for their fathers. Washington University clinical psychologist, Dr. Jennifer Romo, offers her expertise in helping caregivers. Through Siteman's support groups and individual sessions she helps them find balance in their lives, and validates their need to express and process the full spectrum of emotions.      “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/siteman-psychology-service/ https://siteman.wustl.edu/visiting/patient-and-family-services/ https://www.cancersupportcommunity.org/ https://annieshope.org/ https://www.cancer.org/cancer/caregivers.html https://www.cancer.gov/about-cancer/coping/caregiver-support https://siteman.wustl.edu/treatment/survivorship/

Dr. Randi Mozenter, psychologist and part of the Clinical Medical Staff at Barnes-Jewish Hospital and Wash U Med School, join us to explain what drives a troubled young mind into committing heinous acts like a school shooting. In light of the St. Louis Metropolitan Police Department releasing the graphic bodycam footage of the CVPA school shooting, we also question how this disturbing imagery impacts the minds of the average viewer.

Dr. Randi Mozenter, Psychologist and part of the Clinical Medical Staff at Barnes-Jewish Hospital and Wash U Med School joins Amy and Chris to talk about the video being released from the CVPA shooting and how our brains sperate real and fake. Voice of the Cardinals John Rooney discusses the Cardinals trade deadline and more. 

KMOX Sports Director Tom Ackerman talks about the Cardinals trade deadline. Joe Blanner, Equity Partner with Law Firm McCarthy, Leonard, and Kaemmerer talks St. Louis being in a 'Demographic Winter'. Dr. Randi Mozenter, Psychologist and part of the Clinical Medical Staff at Barnes-Jewish Hospital and Wash U Med School joins Amy and Chris to talk about the video being released from the CVPA shooting and how our brains sperate real and fake. Voice of the Cardinals John Rooney discusses the trade deadline and Pham coming up big. Finally, Olympics finish the show.

Cancer throws a lot of challenges - physical and mental - at patients. It can impact many areas of life, whether it's deciding if or how to tell loved ones, how to navigate relationship changes or even dealing with depression or anxiety. Licensed clinical psychologist Jessica Vanderlan, PhD, returns to the show to discuss these effects and how to boost mental and emotional well-being. The head of psychological counseling at Siteman Cancer Center, she emphasizes the need to prioritize mental health and offers insight and hope for patients and family members alike.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/siteman-psychology-service/ https://siteman.wustl.edu/treatment/survivorship/ https://siteman.wustl.edu/visiting/patient-and-family-services/ https://www.cancer.org/cancer/survivorship/coping.html https://www.cancersupportcommunity.org/

KMOX Health Editor Fred Bodimer talked with Dr. Tiffany Osborne, Emergency Medicine Physician at Washington University School of Medicine and Barnes Jewish Hospital about the extreme heat and the precautions that need to be taken.

Dr. Kozower, a thoracic surgeon, discusses the role of surgery in lung cancer treatment and the use of surgery in the diagnosis of lung cancer. The conversation then shifts to the PCORI study on lung cancer surveillance, where Dr. Kozower explains that the intensity of surveillance, such as the frequency of CT scans, does not impact survival rates for lung cancer patients in retrospect. We also discuss the future of lung cancer treatments.  This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features this PCORI study by Dr. Kozower. Key Highlights: 1. Surgery is the primary treatment for early-stage lung cancer, serving both curative and diagnostic purposes. 2. Surveillance, including regular follow-up visits and imaging, is crucial for detecting new lung cancers, especially in individuals with a history of the disease. Screening, on the other hand, aims to detect cancer in its early stages in individuals without symptoms. 3. The narrative around lung cancer is changing due to advancements in molecular diagnostics, targeted therapies, and immunotherapy, offering more hope and optimism for patients. About our guest: Benjamin D. Kozower, MD, MPH is a Professor and Vice Chair of Surgery at the Washington University School of Medicine in St. Louis, MO. He completed his General Surgery training at the University of Connecticut in 2004 and his Cardiothoracic Surgery residency at Washington University in 2006. Dr. Kozower worked at the University of Virginia in Charlottesville, VA from 2006-2016 until returning to St. Louis in 2016. He is a General Thoracic Surgeon with a focus in thoracic oncology and directs the Thoracic Robotic Program at Barnes Jewish Hospital. He is also a clinical outcomes and health services researcher with funding from the Agency for Healthcare Research and Quality, the Patient Centered Outcomes Research Institute and the National Cancer Institute. Key Moments: At 7:29 "Surgery is the traditional treatment for early-stage lung cancer, patients who have small tumors typically confined to the lung when hopefully it can be curative." At 14:50 "Everybody's followed after their cancer treatment. What's not clear is how often should we follow people?" At 15:38 "The more frequently I'm seen, the earlier something could be detected and the better I'll do. Makes perfect sense. Unfortunately, I'm not sure it's true."  At 35:41 “Fortunately now we're starting to see the development of targeted therapies for specific [lung cancer] mutations. We're starting to see different types of therapies, and not just chemotherapy, but something called immunotherapy, which stimulates the body's immune system to help fight the cancer. So these things have dramatically changed the paradigm of how we treat lung cancers.” Visit the Manta Cares Website Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. --- Support this podcast: https://podcasters.spotify.com/pod/show/manta-cares/support

In this episode, we're talking to the “father of cardiac arrhythmia surgery”, Dr. James Cox. The former Division Chief of Cardiothoracic Surgery here at WashU Med, Dr. Cox developed surgical procedures for multiple cardiac arrhythmias, including the Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia, automatic atrial tachycardias, atrial flutter, atrial fibrillation and ventricular tachycardia. He is best known for developing the Cox-Maze procedure, the first cure for atrial fibrillation, which he performed for the first time at Barnes Jewish Hospital in 1987. Dr. Cox's contributions and developments forever changed the field of cardiac surgery and have saved countless lives. We hope you enjoy our fascinating discussion with Dr. Cox as much as we did! Title music: World Is Holding Hands by WinnieTheMoog https://creativecommons.org/licenses/by/4.0/legalcode

KMOX Health Editor Fred Bodimer with Dr. Randi Mozenter, Clinical Psychologist on staff at Barnes Jewish Hospital and Washington University School of Medicine talking about fear of bridges after the collapse of the Key Bridge in Baltimore. 

A moment of joy and a moment of deep change converge as patients ring the bell at the end of their treatment. This shift often calls for a different kind of care. Jessica Vanderlan, PhD, a clinical psychologist and manager of Siteman Psychology Service, and Rochelle Hobson, RN, MSN, CHPN, manager of Siteman's Survivorship Program, explain how their specialized training helps patients address the complexities of life after cancer treatment. And Jay, a Siteman Cancer Center patient, shares his first-hand experience navigating anxiety, change, and follow-up scans with help from the program's free mental health services.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/survivorship/ https://siteman.wustl.edu/treatment/siteman-psychology-service/ https://siteman.wustl.edu/visiting/patient-and-family-services/

In Part 2 of our Season 2 premiere we hear from Chelsea, who was diagnosed with HER2-positive breast cancer at age 37. She talks about why the one treatment she didn't want – five months of chemotherapy before undergoing her mastectomy – became her only option. Chelsea also reflects on how daily life as a mom of three became much more difficult. She reached her lowest point but pulled through with support from family and friends. Washington University breast surgeon Katherine Glover-Collins, MD, PhD, and Washington University plastic surgeon Terence Myckatyn, MD, join to explain why Chelsea's treatment plan required aggressive chemotherapy, and the strategy behind her reconstructive surgery.    “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/ https://siteman.wustl.edu/prevention/8-ways/8-ways-to-prevent-breast-cancer/ https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/patient-stories/ https://siteman.wustl.edu/treatment/siteman-psychology-service/ https://siteman.wustl.edu/treatment/survivorship/ https://siteman.wustl.edu/visiting/patient-and-family-services/ https://siteman.wustl.edu/visiting/patient-and-family-services/virtual-support-services/ https://siteman.wustl.edu/treatment/siteman-approach/chemotherapy/scalp-cooling/  

Aleta joins the show to share her battle with breast cancer. Her story begins with her diagnosis and what it was like to share the news with her family. She continues on to talk about going through treatment, only to have the cancer come back and eventually lead her to have a double mastectomy. Washington University radiologist Debbie Bennett, MD, chief of breast imaging, and Washington University clinical psychologist Jennie Romo shed light on the importance of mental and emotional support during those hard days, as well as the therapeutic resources Siteman offers.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/prevention/mammography/locations/mammography-van/  https://siteman.wustl.edu/visiting/patient-and-family-services/siteman-psychology-service/    

Siteman Cancer Center patient, Cheryl, shares the motivation that helped her endure three separate cancer diagnoses, a stem cell transplant and CAR T-cell therapy. Her Washington University medical oncologist, Amanda Cashen, MD, joins to explain the scientific advancements that saved Cheryl's life and allowed Cheryl to hold her first grandchild. Dr. Cashen also highlights new positive trends in treating all blood cancers.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/specialized-programs/stem-cell-transplant-and-cellular-therapies-center/ https://siteman.wustl.edu/treatment/cancer-types/lymphoma/

Diagnosed with cervical cancer at age 28, Mindy faced the emotional turmoil not just of surviving her diagnosis but also of how treatment could affect her plans for making a family. In this episode, she sits down with her Washington University Physicians, gynecologic oncologist Lindsay Kuroki, MD, MSCI and reproductive endocrinologist Kenan Omurtag, MD, to discuss the surgery that saved her life, as well as the physical and emotional complexities of fertility preservation and options available to women and men who face cancer.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/cervical/ https://siteman.wustl.edu/treatment/specialized-programs/gynecologic-oncology/ https://siteman.wustl.edu/facts-about-hpv-cervical-cancer/ https://siteman.wustl.edu/treatment/survivorship/infertility-fertility-preservation/ https://siteman.wustl.edu/visiting/payment-information/  

“If I can save one man's life, I'll have done my job.” In this episode, Kevin, prostate cancer survivor, talks about his crusade to save lives through awareness, with Washington University surgeon and urologist Arnold Bullock, MD, and Washington University medical oncologist Russell Pachynski, MD. They talk openly about a topic that many men find taboo to dispel myths and lay out facts about the No. 2 cause of cancer deaths among men.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/prostate/our-approach/ https://getscreenednow.com/prostate-cancer/ https://siteman.wustl.edu/for-your-health-understanding-prostate-cancer-screening-and-prevention/

In 2022, 11-year-old Addie traveled from central Illinois to Siteman Kids at St. Louis Children's Hospital with a brain tumor so rare that the type wasn't widely known anywhere. Addie and her mom, Ashley, are joined by Addie's child life specialist, Nikki, to discuss the surgery, proton therapy and emotional support that saved Addie's life – and the joy they found along the way.  Later in the episode, Washington University radiation oncologist Stephanie Perkins, MD, and Washington University hematologist-oncologist Margaret Shatara, MD, discuss childhood cancer, the latest advancements and the future of treating pediatric patients.  “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/childhood-cancers/ https://siteman.wustl.edu/visiting/kids/ https://siteman.wustl.edu/ https://siteman.wustl.edu/prevention/8-ways/8-ways-to-better-health-and-a-lower-risk-of-cancer-for-early-adults/

When patients describe their nurse, they often use words such as caregiver, teacher, counselor or friend. Three nurses at Siteman Cancer Center (Shannon, Pam and Julie) join the podcast to share their passion for taking care of cancer patients. Hear what inspired each of these nurses to get into the field – and the advice they share with patients.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/patient-experience/  https://siteman.wustl.edu/treatment/siteman-approach/ https://siteman.wustl.edu/visiting/

Throughout our lives, we all experience a barrage of small “t” traumas, and when facing a crisis, we do whatever we can to get through it. However, once that crisis has passed, people often continue trying to deal with the trauma to re-establish their stability.In March of 2021, amidst all the challenges of the COVID crisis, I had the privilege of interviewing the remarkable Dr. Kemia Sarraf. In our discussion, we dove into the reality of trauma, and Kermia explained how to mitigate its impact. That interview was one of our most popular and impactful interviews ever. This week, we revisit it. Kemia, also known by many as Dr. K, is a physician, educator, and leadership coach with a sub-specialty in leadership and coaching on severe burnout, toxic stress, and trauma. She is the founder and CEO of Lodestar, a professional coaching and consulting firm using a 360-degree trauma-aware container for coaching, coach training, leadership training, and justice, equity, diversity, and inclusion facilitation. Join us today to learn from Dr. K's profound insights as she weaves her personal stories into her extensive coaching experience to navigate the delicate balance between coaching and therapy. This interview will enlighten you and hopefully leave you feeling lighter and more empowered!Show Highlights:Kermia shares her personal experience of trauma and explains how it impacted her life and her workWhat coaching teaches usHow the effects of burnout go far deeper than just the symptomsHow toxic stress impacts individuals and communitiesThe importance of recognizing and addressing small “t” traumasWhat is the difference between coaching and therapy?Why it is essential to understand trauma without necessarily having to know every detail about its causeHow grounding techniques can help people in the midst of a crisis regain controlKermia shares her personal experience with ACEs (Adverse Childhood Events)Why is trauma-informed counseling essential for healing?How trauma mitigation coaches help people recognize their agency and develop the necessary skills to manage traumatic encountersBio: Dr. Kemia Sarraf - or "Dr. K" as she is most often known - is an internist, educator, and physician & leadership coach whose subspecialty paradigm focuses on leadership and coaching in and beyond severe burnout, toxic stress, and the trauma of these times. She is the founder and CEO of Lodestar, a professional coaching and consulting firm that utilizes a 360° trauma-aware container for coaching, coach training, leadership training, and Justice, Equity, Diversity, and Inclusion facilitation.Dr. Sarraf received her Medical Degree and Master of Public Health at the University of Utah School of Medicine and completed her residency in Internal Medicine at Barnes-Jewish Hospital, Washington University School of Medicine. She serves as Adjunct Asst. Professor at Southern Illinois University School of Medicine where she works in the office of Equity, Diversity & Inclusion.A gifted storyteller and much-sought speaker, Dr. K's communication style is deeply intuitive, rooted in both the power of connection and the knowledge that intratraumatic growth is not just aspirational, but possible. Weaving her background and deep understanding of trauma and the multivariate ways in which it "shows up" with her skills as an executive coach, Dr. K's trademarked coaching paradigm has a lens tuned to the vicarious or secondary trauma that is a part of daily life for high achieving, hard-driving, highly skilled professionals in any industry.Blending extensive experience with balance, humor, and endless empathy, Dr. K has helped countless physicians and...

It wasn't Pam's first cancer diagnosis. In fact, because of a rare genetic disorder she has, Pam and her husband, Charlie, expected she would be diagnosed more than once. Together, they faced routine screenings and tests. But pancreatic cancer wasn't expected. An evening call in the fall of 2021 began Pam and Charlie's journey. While she received treatment, he supported her. Washington University medical oncologist Kian-Huat Lim, MD, PhD, and Washington University gastroenterologist Koushik Das, MD, explain how clinical trials, chemotherapy, surgery and new daily med ication make surviving pancreatic cancer possible.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/pancreatic/ https://siteman.wustl.edu/research/learn-about-clinical-trials/ https://siteman.wustl.edu/prevention/genetic-counseling/

Ron had referred patients for biopsies before, but the dentist didn't expect the lump in his own neck to be cancer. As one of a growing number of people diagnosed with HPV-related head and neck cancer, Ron shares about his treatment and why he advocates children being vaccinated against it. Though these cancers are on the rise, Washington University Otolaryngologist, Chief of Surgery at Siteman Cancer Center, Sidharth Puram, MD, PhD explains how HPV vaccines are key for preventing them entirely.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/head-and-neck/ https://siteman.wustl.edu/treatment/cancer-types/head-and-neck/hpv-head-and-neck-cancer/  https://siteman.wustl.edu/prevention/8-ways/8-ways-to-better-health-and-a-lower-risk-of-cancer-for-early-adults/

KMOX Health Editor Fred Bodimer talks with Dr. Jason Newland, Washington University pediatric infectious diseases specialist at Barnes Jewish Hospital about the updated CDC recommendations about which kids should get the RSV shot.

In this episode, Daniel Belkin and Mitch Belkin interview Bryan Carmody, MD, about physician shortages, resident unionization, and the OB/GYN ERAS divorce. They discuss the recent changes to legislation in Tennessee which allows international medical graduates to bypass the US residency system. They also touch on the Weisman versus Barnes Jewish Hospital court case.If you missed the initial episode with Bryan Carmody Episode #6, be sure to check that out.Who is Bryan Carmody?Dr. Bryan Carmody is a pediatric nephrologist at Eastern Virginia Medical School. He has made a name for himself as a critic of certain aspects of medical education and the residency application process.Support the showFollow us at @ExMedPod Subscribe to our Youtube channelConsider supporting us on Patreon

KMOX Health Editor Fred Bodimer talked with Dr. Marc Sintek, a Washington University cardiologist at Barnes Jewish Hospital about the connection between the flu and heart attacks. 

Do I need to have my breast removed? Will I lose them both? What about my nipples - will I get to keep them? How long before I can get reconstruction? Will I ever feel the same again? The unknowns women face after getting a breast cancer diagnosis are staggering. Our Season 2 premiere launches into the physical and emotional toll that breast cancer survivors endure. The experience and honesty they share took two whole episodes to convey. In Part 1, survivors Melanie and Tamara open up about their mastectomies, the challenges they were prepared for and the impact(s) they didn't expect.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.  For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/ https://siteman.wustl.edu/prevention/8-ways/8-ways-to-prevent-breast-cancer/ https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/patient-stories/ https://siteman.wustl.edu/treatment/siteman-psychology-service/ https://siteman.wustl.edu/treatment/survivorship/ https://siteman.wustl.edu/visiting/patient-and-family-services/ https://siteman.wustl.edu/visiting/patient-and-family-services/virtual-support-services/ https://siteman.wustl.edu/treatment/survivorship/body-image/ https://psychiatry.wustl.edu/patient-care-3/services-treatments/

"This is Cancer" returns for a second season - honest, compelling, and inspiring stories from cancer patients and the physicians who put forth miraculous efforts to treat them. This series is the perfect companion podcast - not only for people who've been touched by cancer, but for those of us who simply love the human experience. Brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, National Leaders in Cancer. "This is Cancer" premieres everywhere May 10th. “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO. For more information, visit siteman.wustl.edu

Resources, age, and mindset each play a key role in developing cancer treatment plans. Washington University radiation oncologist Lannis Hall, MD, MPH and former Siteman radiation therapist Larissa Bullock discuss how they take patients' unique challenges, like food insecurity, transportation, fertility, and psychological health, into account. Both explain why expert cancer care includes real support for tangible needs.    “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on Siteman Cancer Center, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/prevention/pecad/ https://siteman.wustl.edu/treatment/survivorship/ https://siteman.wustl.edu/visiting/patient-and-family-services/  

Why are two dissimilar cancers so commonly confused? Washington University radiation oncologist Maria Thomas, MD, PhD, and Washington University medical oncologist Neha Mehta-Shah, MD explain the differences and similarities of leukemia and lymphoma.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/treatment/cancer-types/leukemia/ https://siteman.wustl.edu/treatment/cancer-types/lymphoma/ 

Host, Laura Susic, recently underwent genetic counseling - which resulted in her qualification for increased screenings. In this bonus episode, Laura shares the anxiety and stress she felt when Washington University physicians found a suspicious lump during her first breast MRI. Laura relates to co-host, Patrick, about the agony of waiting for the biopsy results and the fear of hearing, “This is Cancer.”   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on Siteman Cancer Center, go to: https://siteman.wustl.edu/  

In Episode 8 of This is Cancer, we honor the life of our colleague and dear friend, Jenny Miller. In the summer of 2022, the 33-year-old mother of two was diagnosed with a rare, stage-4 adrenal cancer. While Jenny was in treatment, she wanted to share her story on the podcast. Sadly, she passed away just two months later. You'll hear Jenny's inspiring attitude and the unwavering positivity she used to face her diagnosis. Her colleague and close friend, Rachel Cliffe, joins us to share the joy of knowing her and the grief that came with losing her. We want to thank Jenny's husband and family for allowing us to share this episode. We love you, Jenny.    “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/

In 2021, our host Patrick (a cancer survivor himself) lost his father, Paul, to skin cancer. Washington University medical oncologist Jesse Keller, MD, who cared for Paul for years, joins us to reflect on the relationships that form between doctors, patients and their families. We also explore the value of hospice care as another form of treating cancer.    “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/visiting/patient-and-family-services/kidscan/ https://siteman.wustl.edu/prevention/genetic-counseling/ https://siteman.wustl.edu/treatment/cancer-types/skin/symptoms-risk-and-prevention/

When Justin noticed a dip in his competitive cycling performance, a visit to the chiropractor led to the discovery of Hodgkin's lymphoma. Washington University radiation oncologist Maria Thomas, MD, PhD, and Washington University medical oncologist Neha Mehta-Shah, MD, recount Justin's elite perseverance and championship attitude that got him through a marathon of chemotherapy, radiation and a stem cell transplant.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/visiting/patient-and-family-services/kidscan/ https://siteman.wustl.edu/prevention/genetic-counseling/ https://siteman.wustl.edu/treatment/cancer-types/skin/symptoms-risk-and-prevention/

Because Danielle has a strong family history of breast cancer, her doctor continuously pushed her to get genetic counseling. And it's a good thing she did – Danielle's assessment led to the discovery of breast cancer in its early stages, when it's easier to treat. Now, Danielle is a survivor and eager to share her journey. Washington University geneticist Amy Cyr, MD, joins the conversation to emphasize the need for more awareness about genetic screenings and counseling. She also discusses how she recently helped our host, Laura, make a plan for her own genetic breast cancer risk.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/prevention/mammography/locations/mammography-van/  https://siteman.wustl.edu/prevention/ydr/ https://siteman.wustl.edu/prevention/genetic-counseling/

Teri was training to qualify for the Ironman World Championship when she was diagnosed with stage 4 colorectal cancer in 2009. Now, over a decade later, she is considered to have no evidence of disease. Teri shares her incredible story of resilience in the hopes of inspiring others and saving lives. She is joined by Washington University gastroenterologist Jean Wang, MD, PhD, to talk about advances in treatment and the importance of early detection.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/visiting/patient-and-family-services/siteman-psychology-service/ https://siteman.wustl.edu/treatment/cancer-types/skin/symptoms-risk-and-prevention/ https://siteman.wustl.edu/prevention/smoking-cessation-program/ https://www.poweredbyhope.org/ https://www.pedalthecause.org/

Sometimes, the best way to deal with a cancer diagnosis is to accept that we can't always control it. In this episode, ovarian cancer survivor Larissa and Washington University radiation oncologist Lannis Hall, MD, MPH, reflect on their relationship and how they went from former coworkers at Siteman to cancer patient and doctor.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/ https://siteman.wustl.edu/prevention/ydr/ https://siteman.wustl.edu/visiting/patient-and-family-services/kidscan/ www.yourdiseaserisk.comhttps://siteman.wustl.edu/prevention/genetic-counseling/